Imipramine
- TRADE NAMES: Apo-Imipramine; Imidol; Imipramin; Impril; Novo-Pramine; Primonil; Pryleugan; Tofranil (Mallinckrodt)
- INDICATIONS: Depression
- CLASS: Antidepressant; tricyclic, Muscarinic antagonist
- HALF-LIFE: 6–18 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amprenavir, Arbutamine, Artemether/Lumefantrine, Clonidine, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Darifenacin, Epinephrine, Fluoxetine, Formoterol, Guanethidine, Iobenguane, Isocarboxazid, Labetalol, Linezolid, MAO inhibitors, Phenelzine, Propranolol, Quinolones, Ropivacaine, Sparfloxacin, Tranylcypromine, Zaleplon, Zolpidem
PREGNANCY CATEGORY: D
SUICIDALITY AND ANTIDEPRESSANT DRUGS
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
OTHER.
Page last updated 11/10/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric